Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jacob R. Hartman is active.

Publication


Featured researches published by Jacob R. Hartman.


Free Radical Research | 1991

RECOMBINANT HUMAN SUPEROXIDE DISMUTASES: PRODUCTION AND POTENTIAL THERAPEUTICAL USES

Marian Gorecki; Yaffa Beck; Jacob R. Hartman; Meir Fischer; Lola Weiss; Zelig Tochner; Shimon Slavin; Abraham Nimrod

In many pathological situations, tissue damage is caused by cellular generation of superoxide free radicals (O2-). These active species are generated during post-ischemic reperfusion of organs, in hyperoxic tissue, during acute and chronic inflammation and during exposure to ionizing radiation. Exogenous superoxide dismutase (SOD) was shown to significantly prevent such damage. The genes for human cytosolic Cu/ZnSOD and mitochondrial MnSOD were cloned and introduced into an E. coli expression system. The proteins were expressed in high yields and purified to homogeneity, yielding pharmaceutical-grade materials. These enzymes were used in a variety of in vivo animal models for the demonstration of their protective effects against oxidative damage. Comparative pharmacokinetic studies in rats have revealed that the half-life of Cu/ZnSOD was 6-10 min., while that of MnSOD was 5-6 hours, thus indicating that MnSOD may be superior to Cu/ZnSOD for the treatment of chronic diseases. Indeed, MnSOD was found to be effective as an anti-inflammatory agent in the rat carrageenan induced paw edema acute inflammation model. Both enzymes were also effective in ameliorating post-irradiation damage in mice exposed to whole-body or localized chest X-ray radiation.


Cell | 1977

Inhibition of viral protein synthesis in monkey cells treated with interferon late in simian virus 40 lytic cycle.

Emanuel Yakobson; Carol Prives; Jacob R. Hartman; Ernest Winocour; Michel Revel

We have investigated the effect of interferon on SV40 gene expression late in the lytic cycle, after early functions have been expressed and viral DNA replication has been initiated. Whereas pretreatment with interferon prior to infection reduces the amount of early SV40 RNA, post-infection treatment does not inhibit viral RNA synthesis. Viral 19S and 16S RNA species are found undiminished in quantity and poly(A) content. Despite the apparent normalcy of viral RNA classes, however, there is a marked reduction in the synthesis of their protein products, both T antigen and capsid polypeptides. The association of viral RNA with heavy polyribosomes is strongly reduced. On the other hand, there is no degradation of nonviral polyribosomes and the synthesis of most cellular proteins continues. These experiments demonstrate that late in infection, interferon treatment results in an inhibition of viral mRNA translation.


Journal of Molecular Biology | 1989

Characterization of crystals of genetically engineered human manganese superoxide dismutase

Ulrike Wagner; Moshe M. Werber; Yaffa Beck; Jacob R. Hartman; Felix Frolow; Joel L. Sussman

The genetically engineered human manganese superoxide dismutase crystallizes in space group P2(1)2(1)2 with a = 75.51 A, b = 79.00 A, c = 67.95 A. At room temperature the crystals are not stable against radiation, so we cooled them to 90 K and collected a data set to 3 A resolution at this temperature.


Archive | 1988

Plasmids for expression of human superoxide dismutase (SOD) analogs containing lambda PL promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereof

Jacob R. Hartman; Amos B. Oppenheim; Marian Gorecki; Haim Aviv


Nucleic Acids Research | 1987

Human Mn superoxide dismutase cDNA sequence

Yaffa Beck; Rachel Oren; Boaz Amit; Avigdor Levanon; Marian Gorecki; Jacob R. Hartman


Archive | 1992

Therapeutic compositions comprising a mixture of human CuZn superoxide dismutase analogs

Jacob R. Hartman; Amos B. Oppenheim; Marian Gorecki; Haim Aviv; Rachel Oren


Archive | 1992

Sod polypeptide analogs

Jacob R. Hartman; Amos B. Oppenheim; Marian Gorecki; Haim Aviv; Rachel Oren


Nature Biotechnology | 1988

Efficient production of active human manganese superoxide dismutase in Escherichia coli

Yaffa Beck; Daniel Bartfeld; Ziva Yavin; Avigdor Levanon; Marian Gorecki; Jacob R. Hartman


Archive | 1984

Method for producing enzymatically active eucaryotic sod in bacteria

Jacob R. Hartman; Dov Kanner; Daniel Bartfeld


Archive | 1988

Human manganese superoxide dismutase and methods of treatment

Jacob R. Hartman; Yaffa Beck; Abraham Nimrod

Collaboration


Dive into the Jacob R. Hartman's collaboration.

Top Co-Authors

Avatar

Marian Gorecki

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Yaffa Beck

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Avigdor Levanon

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Amos B. Oppenheim

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Haim Aviv

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Hilla Locker-Giladi

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Moshe M. Werber

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Rachel Guy

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Rachel Oren

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Tikva Vogel

Hebrew University of Jerusalem

View shared research outputs
Researchain Logo
Decentralizing Knowledge